...
首页> 外文期刊>Carbohydrate research >Synthesis of chitotetraose and chitohexaose based on dimethylmaleoyl protection
【24h】

Synthesis of chitotetraose and chitohexaose based on dimethylmaleoyl protection

机译:基于二甲基马来酰基保护的壳四糖和壳六糖的合成

获取原文
获取原文并翻译 | 示例
           

摘要

tert-Butyldimethylsilyl 3,6-di-0-benzyl-2-deoxy-2-dimethylmaleimido-#beta#-D-glucopyranoside was readily trans- formed into the disaccharide glycosyl donor, 3,4,6-tri-0-acetyl-2-deoxy-2-dimethylmaleimido#alpha# -#beta#-D-glucopyranosyl- (1-+4)-3,6-di-0-benzyl-2-deoxy-2-dimethylmaleimido-(X/~-D-glucopyranosyl trichloroacetimidate, and the disaccharide glycosyl acceptor, tert -butyldimethylsilyl 3,6-di-0-benzyl-2-deoxy-2-dimethylmaleimido-#beta#-D-glucopyra- nosyl-(1-+4)-3,6-di-0-benzyl-2-deoxy-2-dimethylmaleimido-#beta#-D-glucopyranoside. A TMSOTf-catalysed coupling of the acceptor with the donor afforded the respective tetrasaccharide derivative, which can be transformed to chitotetraose. tert -Butyldimethylsilyl 3, 6-di -0- benzyl- 2-deoxy-2-dimethylmaleimido-4- 0- phenoxyacetyl-#beta#- D-glucopy - ranosyl-(l -+ 4)-3,6-di-0-benzyl-2-deoxy-2-dimethylmaleimido-#beta#-D-g1ucopyranoside was converted into donor 3,6-di- 0- benzyl-2-deoxy-2-dimethylmaleimido-4- O-phenoxyacetyl-#beta#-D-glucopyranosyl-(l -.4)- 3,6-di -0- benzyl- 2-deoxy-2- dimethylmaleimido-#beta#-D-glucopyranosyl trichloroacetimidate. Its coupling with benzyl 3,6-di-0-benzyl-2-deoxy-2- dimethylmaleimido-#beta#-D- glucopyranosyl-( 1 -.4)- 3, 6-di -0- benzyl- 2-deoxy -2-dimethylmaleimido-#beta#-D- glucopyranoside, followed by dephenoxyacetylation, gave benzyl 3,6-di-0-benzyl-2-deoxy-2-dimethylmaleimido-#beta#-D-glucopyranosyl- (1-+4)-3,6-di- 0- benzyl-2-deoxy-2-dimethylmaleimido-#beta#-D-glucopyranosyl-(l -.4)- 3,6-di- 0- benzyl-2-deoxy-2- dimethylmaleimido-#beta#-D-glucopyranosyl-( 1 -.4)- 3, 6-di -0- benzyl- 2-deoxy -2-dimethylmaleimido-#beta#-D- glucopyranoside, whose glycosylation furnished, after replacement of the DMM-group by the acetyl moiety and subsequent deprotection, chitohexaose. @ 2001 Elsevier Science Ltd. All rights reserved.
机译:叔丁基二甲基甲硅烷基3,6-二-0-苄基-2-脱氧-2-二甲基马来酰亚胺基-#β#-D-吡喃葡萄糖苷很容易转化为二糖糖基供体3,4,6-三-0-乙酰基-2-脱氧-2-二甲基马来酰亚胺基#alpha#-#beta#-D-吡喃葡萄糖基-(1- + 4)-3,6-二-0-苄基-2-脱氧-2-二甲基马来酰亚胺基-(X /〜- D-吡喃葡萄糖基三氯乙酰亚氨酸酯和二糖糖基受体叔丁基二甲基甲硅烷基3,6-二-0-苄基-2-脱氧-2-二甲基马来酰亚胺基-#beta#-D-吡喃葡萄糖基-(1- + 4)-3 ,6-二-0-苄基-2-脱氧-2-二甲基马来酰亚胺基-ββ--D-吡喃葡萄糖苷。TMSOTf催化的受体与供体的偶联提供了相应的四糖衍生物,可以将其转化为壳四糖。 -丁基二甲基甲硅烷基3,6-二-0-苄基-2-脱氧-2-二甲基马来酰亚胺-4--0-苯氧基乙酰基-#beta#-D-葡萄糖基-核糖基-(1- + 4)-3,6-di-0 -苄基-2-脱氧-2-二甲基马来酰亚胺基-#beta#-D-g1ucopyranoside被转化为供体3,6-di-0-苄基-2-脱氧-2-二甲基马来酰亚胺基-4-O-苯氧基乙酰基-#beta#-葡萄糖吡喃糖基-(1-.4)-3,6-二-0-苄基-2-脱氧-2-二甲基马来酰亚胺基-β-β-D-吡喃葡萄糖基三氯乙酰基亚氨酸酯。其与苄基3,6-二-0-苄基-2-脱氧-2-二甲基马来酰亚胺基-#β#-D-吡喃吡喃糖基-(1 -.4)-3,6-二-0-苄基-2-脱氧-2-二甲基马来酰亚胺基-#beta#-D-吡喃葡萄糖苷,然后脱苯氧基乙酰化,得到苄基3,6-二-0-苄基-2-脱氧-2-二甲基马来酰亚胺基-βbeta--D-吡喃葡萄糖基-(1- + 4 )-3,6-二-0-苄基-2-脱氧-2-二甲基马来酰亚胺基-#β#-D-吡喃葡萄糖基-(1-.4)-3,6-二-0-苄基-2-脱氧-2 -二甲基马来酰亚胺基-#beta#-D-吡喃葡萄糖基-(1 -.4)-3,6-二-0-苄基-2-脱氧-2-二甲基马来酰亚胺基-βbeta#-D-吡喃葡萄糖苷,替换后具有糖基化作用通过乙酰基部分除去DMM-基团,然后脱去壳六糖。 @ 2001 Elsevier ScienceLtd。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号